Tivic Health Systems (TIVC)
Develops TLR5 immunotherapies and biomanufacturing services for radiation and oncology uses.
$0.2577
At close−0.03 (−10.46%)
No recent trading data
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≥ 1.79% | 398.1K shares | |
|---|---|---|---|
| 13 holders · as of Jun 30, 2026 | |||
| Insiders | 0.32% | 71.0K shares | |
| 5 holders · as of Apr 20, 2026 | |||
| Other | ≤ 97.89% | 21.72M shares | |
| remainder | |||
22.19M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (22.19M in the company's Sep 22, 2026 report, 1.08M elsewhere); stakes use the report.
Institutional filings for VBIO (100% of the company) are not on file here, so the institutional figure is a floor.
13F, as of Jun 30, 2026
13 holders · 398.1K shares · 5 new positions · 7 increased · 3 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Murchinson Ltd. | 115.0K | 0.52% | +115.0Knew | Aug 14, 2026 |
| Citadel Advisors LLC | 74.1K | 0.33% | +74.1Knew | Sep 2, 2026 |
| Sanctuary Advisors, LLC | 61.2K | 0.28% | 0 | Aug 13, 2026 |
| Marex Group PLC | 54.3K | 0.24% | −5.0K | Aug 14, 2026 |
| Virtu Financial LLC | 39.2K | 0.18% | +39.2Knew | Aug 13, 2026 |
| Geode Capital Management, LLC | 19.4K | 0.09% | −68.4K | Aug 12, 2026 |
| HRT Financial LP | 11.5K | 0.05% | −31.0K | Aug 14, 2026 |
| UBS Group AG | 11.1K | 0.05% | +8.7K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| 3i, LPincl. Tumim Stone Capital, LLC, Maier J. Tarlow +1 more | 9.90% | 13D | Aug 27, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 15, 2026 | Sheryle Boltondirector | Purchase | 10,000 | $1.04 | 10,000 |
| Apr 1, 2026 | Christina Rizopoulos Valauridirector | Purchase | 19,000 | $0.9478 | 19,000 |
House and Senate disclosures
Not reported.